Searching…
Learn more about CAMZYOS™ Risk Evaluation and Mitigation Strategy (REMS), including how to get certified and how to manage your REMS tasks online.
Use the prescriber login to get certified and manage REMS tasks and your patients. Find additional resources and enrollment information here.
These medicines can affect the amount of CAMZYOS in their blood. As part of the REMS, your healthcare provider will discuss these interactions with CAMZYOS, including examples of which over-the-counter medicines and s...
CAMZYOS® REMS Patient Enrollment Form ⊲ Complete this form online at CAMZYOSREMS.com, or ⊲ Print and complete this form and submit by fax to the CAMZYOS REMS at 833-299-9539 ... Page 1
What is the CAMZYOS REMS? A Risk Evaluation and Mitigation Strategy (REMS) is a strategy to manage known or potential risks associated with a drug product and is required by the Food and Drug Administration (FDA) to e...
A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the US Food and Drug Administration (FDA) can require for certain medicines to ensure they are used safely.
This form must be submitted in its entirety on the appropriate REMS program schedule in order for your patient to receive CAMZYOS. Failure to submit the Patient Status Form may result in dispensing holds and potential...
Find downloadable resources for prescribers, pharmacies, and patients participating in the CAMZYOS™ REMS program.
Ad-hoc Patient Status Forms are used to deactivate a patient (ie, unauthorize a patient from receiving CAMZYOS), enable dose adjustments OR to reactivate patients who have been deactivated for less than 90 days.
Document and submit confirmation of an echocardiogram, assessment of drug-drug interactions, and authorization for continuing treatment to the CAMZYOS REMS using the Patient Status Form
